Simpler HIV pill tested for seniors to reduce side effects
NCT ID NCT06444620
Summary
This study is testing if switching older adults with well-controlled HIV from a three-drug pill to a simpler two-drug pill is just as effective and safe. It involves 240 participants in Kenya aged 60 and over who will take the new pill for two years. The main goal is to see if the simpler treatment keeps the virus under control while potentially reducing long-term side effects like kidney and bone problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jaramogi Oginga Odinga Teaching and Referral Hospital
Kisumu, Kenya
-
Kenyatta National Hospital
Nairobi, Kenya
Conditions
Explore the condition pages connected to this study.